Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.
BackgroundBudesonide foam is effective in inducing Ready Meals clinical remission in ulcerative colitis (UC) patients with active proctosigmoiditis.The aim of this study was to evaluate the duration of remission and predictors of relapse in UC patients who achieved clinical remission and mucosal healing by 6-week treatment with topical budesonide.M